Overview

HKI-272 Ketoconazole Drug Interaction Study

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To investigate a potential pharmacokinetic drug interaction between HKI-272 and ketoconazole when co-administered.
Phase:
Phase 1
Details
Lead Sponsor:
Puma Biotechnology, Inc.
Treatments:
Ketoconazole